Development of a risk model to predict prognosis in breast cancer based on cGAS-STING-related genes
Source check: Source checked. Not independent scientific confirmation.
Finding: A model based on 11 cGAS-STING-related genes stratified overall survival across breast-cancer expression cohorts. The reported associations are retrospective prognostic signals and do not establish causal biology or clinical utility. The result remains bounded to the reported datasets and assays.
Technology: Cox-regression risk model
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Cox regression selected 11 cGAS-STING-related genes for a breast-cancer survival risk model.
- Test and result
- A model based on 11 cGAS-STING-related genes stratified overall survival across breast-cancer expression cohorts. The reported associations are retrospective prognostic signals and do not establish causal biology or clinical utility.
- Limitation / still unknown
- The source-checked evidence does not establish broader external validity or prospective benefit. Affiliation was not available in the retrieved trusted primary metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3389/fgene.2023.1121018 · https://europepmc.org/article/MED/37051596 · https://europepmc.org/articles/PMC10083333 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC10083333/unicode
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.